Get Social With Us

You’re a Good Man Charlie B

We can all heave a sigh of relief. With his recent announcement that he will extend Gov. Deval Patrick’s 10-year, $1 billion life sciences development package – by five years and $500 million – Massachusetts Governor Charlie Baker has finally signaled, unequivocally, that he recognizes the importance of biotechnology and...

Read More

Challenges in Forecasting Biopharmaceutical Demand and the Value of Flexibility

By: Tom Ransohoff Presented at: BioProcess International West. 27 Feb – 2 Mar, 2017, San Francisco, CA This presentation reviews approaches to achieving manufacturing flexibility along with thoughts on the value of this flexibility. The challenges in forecasting future volumetric demand for biopharmaceutical products are well known. For years, we have maintained a...

Read More

Case study-CMC challenges when a small biosimilar developer must rely on outsourcing for development and manufacturing

By: Patti Seymour Presented at: Drug Information Association CMC Workshop. 24-26 Apr, 2017, New York, NY This presentation is a case study that explores the CMC and manufacturing challenges facing a small biosimilar developer. Biosimilar market is expected to grow to ~$40 billion by 2020, which is attracting a large field of competitors....

Read More

The Value of Flexible Technologies

If you had any doubt that single-use technologies are becoming broadly accepted for commercial biopharmaceutical manufacturing applications, the recent BPI-West conference should put them to rest. The infrastructure and systems are being established at many large manufacturers to enable them to control single-use supply chains for both clinical and commercial...

Read More